Lianhe Zaobao: Do All Patients with Follicular Lymphoma Need Immediate Treatment?
Media By: Dr Joanne Lee (Published in Lianhe Zaobao, 9 September 2025) Follicular lymphoma (FL) is a slow-growing, chronic form of non-Hodgkin lymphoma that usually progresses gradually over many years. Many patients can remain in good health for long periods without needing immediate treatment. In Singapore, about 800 new lymphoma cases are diagnosed each year, […]
96.3好FM《津津乐道》：深入了解滤泡性淋巴瘤
Media 李医生于10月29日在好FM…
DLBCL Journey of Catherine Choo: A story of Hope, Resilience, and Recovery from Lymphoma
Life was humming along beautifully for Catherine Choo. A successful professional and dedicated mother in her late 40s, she thrived at work and home. Her days were packed, but she loved the energy and purpose of juggling career and motherhood. That was until May 2024. From Breathlessness to Diagnosis: The Early Signs of DLBCL In […]
Bringing Global Practice to Local Care: How We Treat First-Line DLBCL in Singapore – Highlights from the International Conference on Translational Medicine and Innovation of Blood Diseases 2025
Media Dr. Joanne Lee was honoured to present at the International Conference on Translational Medicine and Innovation of Blood Diseases 2025, held in Shanghai on “How We Treat First-Line DLBCL in Singapore”. The conference was jointly organized by the Shanghai Institute of Hematology, Ruijin Hospital, and the National Facility for Translational Medicine (Shanghai). Dr. Lee […]
Personalized Pathways in CLL and MCL: Highlights from MSH 2025 by Dr. Joanne Lee
Media At the 2025 Malaysian Society of Haematology (MSH) Annual Scientific Meeting, Dr. Joanne Lee presented two highly anticipated sessions that explored precision medicine approaches in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL), emphasizing the evolving role of targeted therapy, risk stratification, and individualized care. In her first talk, “Optimizing the Role of […]
Navigating Through the Challenges of Living With Human Immunodeficiency Virus (HIV) and Lymphomas
T-cells, also known as T lymphocytes, are crucial to the immune system, which combats infection-causing pathogens (such as viruses, bacteria, fungi, and parasites) to eliminate harmful cells, like cancer cells. Human immunodeficiency virus (HIV) infection leads to a gradual decline in the function and number of a special type of T-cells called CD4+ helper T-cells […]
Older Patients With Relapsed Refractory Diffuse Large B cell Lymphoma Treated With Axi-cel Have Better Outcomes Compared With Chemoimmunotherapy
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and patients with relapsed or refractory disease often have poor prognoses. This is particularly true for older adults, with comorbidities along with an increased risk for mortality and severe toxicity from intensive salvage chemoimmunotherapy (CIT) and may not be eligible for autologous […]
Treatment Options of Relapsed/Refractory Diffuse Large B cell Lymphoma (DLBCL)
“Relapsed” means the disease comes back after an improvement, while “refractory” means the lymphoma is not responding to treatment or the response is very short-lived. The majority (Up to 50-60%) of patients with Diffuse Large B cell lymphoma (DLBCL) can be potentially cured with standard chemoimmunotherapy, R-CHOP. 1 Even amongst patients who progress during initial […]
After a Lymphoma Diagnosis: Everything You Need To Know
A diagnosis of lymphoma can upend lives, triggering a cascade of questions and uncertainties. From understanding the nature of lymphoma to grasping the treatment choices, this article is your guide through the extensive information surrounding this condition. Whether you’re a patient grappling with the diagnosis or a support pillar for someone facing it, this article […]
Health Matters – Diffuse Large B Cell Lymphoma
Media Daniel Martin speaks with Dr Lim Zi Yi, Medical Director of Centre for Clinicial Haemotology, and a Senior Consultant in Haematology, about the most common lymphoma known as Diffuse large B cell lymphoma (DLBCL). This can present as a rapidly growing mass or enlarged lymph nodes. What is the latest being done to tackle […]